BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 215 filers reported holding BRIDGEBIO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,724,891 | +37.0% | 103,333 | -10.6% | 0.00% | +33.3% |
| Q2 2023 | $1,988,767 | +21.8% | 115,626 | +17.4% | 0.00% | +50.0% |
| Q1 2023 | $1,632,914 | +113.1% | 98,487 | -2.0% | 0.00% | +100.0% |
| Q4 2022 | $766,092 | -21.7% | 100,537 | +2.1% | 0.00% | -50.0% |
| Q3 2022 | $979,000 | +6.4% | 98,503 | -2.8% | 0.00% | +100.0% |
| Q2 2022 | $920,000 | -7.1% | 101,353 | +3.9% | 0.00% | 0.0% |
| Q1 2022 | $990,000 | -48.2% | 97,539 | -14.9% | 0.00% | -50.0% |
| Q4 2021 | $1,912,000 | -63.9% | 114,645 | +1.3% | 0.00% | -71.4% |
| Q3 2021 | $5,302,000 | -41.4% | 113,122 | -23.7% | 0.01% | -36.4% |
| Q2 2021 | $9,041,000 | +3.4% | 148,304 | +4.5% | 0.01% | -8.3% |
| Q1 2021 | $8,742,000 | +11.5% | 141,910 | +28.8% | 0.01% | +9.1% |
| Q4 2020 | $7,837,000 | +89.5% | 110,215 | +0.0% | 0.01% | +57.1% |
| Q3 2020 | $4,135,000 | +15.5% | 110,202 | +0.4% | 0.01% | +16.7% |
| Q2 2020 | $3,581,000 | +8.4% | 109,805 | -3.6% | 0.01% | -14.3% |
| Q1 2020 | $3,302,000 | +172.9% | 113,860 | +229.9% | 0.01% | +250.0% |
| Q4 2019 | $1,210,000 | +60.1% | 34,510 | -2.0% | 0.00% | +100.0% |
| Q3 2019 | $756,000 | – | 35,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
| Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
| Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
| M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
| VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
| BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
| Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |